Search research articles
Contact Us
Filters
Showing results (141-150 of 171) with videos related to
Page
of 18
Sort By:
JAMA Network Open
|
October 15, 2024
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical Trial
Soumyajit Roy, Shawn Malone, Kevin Wing, et al.
Journal for Immunotherapy of Cancer
|
August 16, 2023
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
Vaia Florou, Charalampos S Floudas, Asaf Maoz, et al.
The Oncologist
|
March 5, 2026
Molecular Landscape of Prostate Cancers with Clival Metastases
Pornlada Likasitwatanakul, Steven M Blinka, Jabra G Zarka, et al.
Journal for Immunotherapy of Cancer
|
March 18, 2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)
Gliceida M Galarza Fortuna, Daniel Grass, Benjamin L Maughan, et al.
The Oncologist
|
March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
Meredith N Freeman, Albert Jang, Jason Zhu, et al.
Research Square
|
July 3, 2023
Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma: a retrospective analysis
Julie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, et al.
The Prostate
|
April 1, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting
Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, et al.
European Urology
|
March 14, 2024
Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study
Soumyajit Roy, Fred Saad, Shawn Malone, et al.
JCO Oncology Practice
|
June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
Christina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
Clinical Proteomics
|
April 18, 2025
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer
Hyejung Lee, Jincheng Shen, Muhammad Zaki Fadlullah, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 171) with videos related to
Sort By:
Page
of 18
JAMA Network Open
|
October 15, 2024
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical Trial
Soumyajit Roy, Shawn Malone, Kevin Wing, et al.
Journal for Immunotherapy of Cancer
|
August 16, 2023
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
Vaia Florou, Charalampos S Floudas, Asaf Maoz, et al.
The Oncologist
|
March 5, 2026
Molecular Landscape of Prostate Cancers with Clival Metastases
Pornlada Likasitwatanakul, Steven M Blinka, Jabra G Zarka, et al.
Journal for Immunotherapy of Cancer
|
March 18, 2025
Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)
Gliceida M Galarza Fortuna, Daniel Grass, Benjamin L Maughan, et al.
The Oncologist
|
March 11, 2022
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
Meredith N Freeman, Albert Jang, Jason Zhu, et al.
Research Square
|
July 3, 2023
Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma: a retrospective analysis
Julie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, et al.
The Prostate
|
April 1, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting
Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh, et al.
European Urology
|
March 14, 2024
Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study
Soumyajit Roy, Fred Saad, Shawn Malone, et al.
JCO Oncology Practice
|
June 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline
Christina M Lockwood, Hans J Messersmith, Annette S Kim, et al.
Clinical Proteomics
|
April 18, 2025
Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer
Hyejung Lee, Jincheng Shen, Muhammad Zaki Fadlullah, et al.
Page
of 18